Global GLP-1 Receptor Agonist Market By Product Type (Semaglutide, Liraglutide, Exenatide, Dulaglutide, and Others), By Route of Administration (Parenteral and Oral), By Application (Type 2 Diabetes Mellitus, Obesity, and Others), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034
- Published date: April 2025
- Report ID: 147312
- Number of Pages: 327
- Format:
-
-
-
- Sun Pharmaceutical Industries Ltd
- Sanofi Company Profile
- Pfizer.Inc
- Novo-Nordisk A/S
- Eli Lilly and Company
- Boehringer Ingelheim International GmbH
- AstraZeneca Plc Company Profile
- Amylyx Pharmaceuticals
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible